ESR1 and neoplasm: Estrogen and progesterone receptor (ER and PR, respectively) signaling pathways are mitogenic in HR+ tumor cells by regulating cyclin D1 and increasing its activity, which results in exacerbated cell proliferation through the cyclin D1–CDK4/6 axis [12,13].